AxoGen (AXGN) Reports In-Line Q2 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to AxoGen (AXGN) Reports In-Line Q2 EPS

AxoGen, Inc. Reports 2018 Second Quarter Financial Results

August 1, 2018 4:17 PM EDT

Q2 Revenue of $20.6 million, representing 36% growth over prior year; reiterates full year 2018 guidance

ALACHUA, Fla., Aug. 01, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today reported financial results and business highlights for the second quarter ended June 30, 2018.

Second Quarter 2018 Financial Results and Recent Business Highlights

Revenue of $20.6 million, up 36% compared to $15.2 million in the second quarter of 2017Revenue from direct sales channel continues to grow above 40% and now accounts for... More